Thomas Daniel Shipp, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Ultrasonography, Prenatal | 46 | 2023 | 1755 | 3.390 |
Why?
|
Uterine Rupture | 14 | 2021 | 65 | 1.770 |
Why?
|
Trial of Labor | 14 | 2021 | 81 | 1.590 |
Why?
|
Placenta Accreta | 4 | 2023 | 237 | 1.120 |
Why?
|
Vaginal Birth after Cesarean | 9 | 2004 | 61 | 0.910 |
Why?
|
Fetal Diseases | 10 | 2017 | 913 | 0.870 |
Why?
|
Uterine Hemorrhage | 7 | 2020 | 240 | 0.870 |
Why?
|
Cesarean Section | 14 | 2023 | 1396 | 0.830 |
Why?
|
Placenta Previa | 1 | 2023 | 122 | 0.800 |
Why?
|
Umbilical Cord | 2 | 2018 | 179 | 0.680 |
Why?
|
Pregnancy | 72 | 2023 | 29862 | 0.580 |
Why?
|
Imaging, Three-Dimensional | 11 | 2018 | 4063 | 0.560 |
Why?
|
Pregnancy Trimester, Second | 12 | 2014 | 731 | 0.490 |
Why?
|
Uterus | 5 | 2023 | 649 | 0.480 |
Why?
|
Down Syndrome | 8 | 2014 | 901 | 0.430 |
Why?
|
Adrenal Glands | 1 | 2015 | 552 | 0.420 |
Why?
|
Placenta | 5 | 2023 | 1708 | 0.410 |
Why?
|
Intrauterine Devices | 2 | 2010 | 113 | 0.400 |
Why?
|
Nuchal Translucency Measurement | 4 | 2014 | 59 | 0.400 |
Why?
|
Pregnancy Trimester, Third | 8 | 2020 | 583 | 0.370 |
Why?
|
Intrauterine Device Migration | 1 | 2010 | 5 | 0.370 |
Why?
|
Cervix Uteri | 4 | 2020 | 570 | 0.360 |
Why?
|
Pregnancy Trimester, First | 4 | 2018 | 907 | 0.340 |
Why?
|
Fetus | 6 | 2014 | 1864 | 0.340 |
Why?
|
Fetal Growth Retardation | 3 | 2019 | 580 | 0.310 |
Why?
|
Endometrium | 4 | 2011 | 403 | 0.300 |
Why?
|
Ultrasonography | 14 | 2020 | 5970 | 0.300 |
Why?
|
Fetal Heart | 3 | 2000 | 281 | 0.300 |
Why?
|
Hysterotomy | 3 | 2021 | 23 | 0.290 |
Why?
|
Radiology | 8 | 2020 | 2113 | 0.290 |
Why?
|
Diagnostic Imaging | 8 | 2020 | 3530 | 0.290 |
Why?
|
Premature Birth | 2 | 2020 | 1782 | 0.290 |
Why?
|
Aneuploidy | 7 | 2014 | 551 | 0.290 |
Why?
|
Ilium | 2 | 1998 | 155 | 0.280 |
Why?
|
Pelvic Pain | 3 | 2016 | 298 | 0.260 |
Why?
|
Adnexal Diseases | 2 | 2019 | 104 | 0.250 |
Why?
|
Sex Preselection | 1 | 2004 | 16 | 0.250 |
Why?
|
Societies, Medical | 11 | 2021 | 3905 | 0.250 |
Why?
|
Pregnancy, High-Risk | 4 | 2016 | 122 | 0.250 |
Why?
|
Pregnancy Outcome | 11 | 2018 | 2920 | 0.240 |
Why?
|
Fetal Death | 4 | 2016 | 435 | 0.230 |
Why?
|
Echocardiography | 2 | 2016 | 4991 | 0.230 |
Why?
|
Female | 96 | 2023 | 392581 | 0.230 |
Why?
|
Maternal Age | 5 | 2002 | 809 | 0.220 |
Why?
|
Climacteric | 1 | 2003 | 57 | 0.220 |
Why?
|
Gestational Age | 11 | 2021 | 3576 | 0.220 |
Why?
|
Puerperal Infection | 1 | 2003 | 44 | 0.210 |
Why?
|
Pregnancy Complications | 6 | 2018 | 2947 | 0.210 |
Why?
|
Ultrasonography, Doppler, Color | 2 | 2013 | 231 | 0.210 |
Why?
|
Ovarian Neoplasms | 5 | 2019 | 4876 | 0.210 |
Why?
|
Head | 2 | 2000 | 924 | 0.200 |
Why?
|
Frontal Bone | 1 | 2002 | 105 | 0.200 |
Why?
|
Image Enhancement | 3 | 2010 | 2884 | 0.200 |
Why?
|
Fathers | 1 | 2004 | 376 | 0.190 |
Why?
|
Chromosome Disorders | 2 | 2002 | 499 | 0.190 |
Why?
|
Premenopause | 3 | 2011 | 1039 | 0.190 |
Why?
|
Prenatal Care | 2 | 2012 | 1139 | 0.190 |
Why?
|
Obstetrics | 4 | 2021 | 665 | 0.180 |
Why?
|
Birth Intervals | 1 | 2001 | 51 | 0.180 |
Why?
|
Endometrial Neoplasms | 2 | 2014 | 1365 | 0.180 |
Why?
|
Trisomy | 1 | 2002 | 260 | 0.180 |
Why?
|
Oligohydramnios | 2 | 2001 | 37 | 0.180 |
Why?
|
Kidney Diseases | 1 | 2011 | 2092 | 0.180 |
Why?
|
Orofaciodigital Syndromes | 1 | 2000 | 21 | 0.180 |
Why?
|
Nose | 2 | 2014 | 521 | 0.180 |
Why?
|
Evidence-Based Medicine | 9 | 2020 | 3687 | 0.180 |
Why?
|
Abnormalities, Multiple | 4 | 2013 | 1424 | 0.170 |
Why?
|
Surgical Wound Dehiscence | 2 | 2011 | 213 | 0.170 |
Why?
|
Myometrium | 3 | 2010 | 174 | 0.170 |
Why?
|
Embryo, Mammalian | 1 | 2006 | 1675 | 0.170 |
Why?
|
Practice Guidelines as Topic | 6 | 2015 | 7389 | 0.170 |
Why?
|
Genital Diseases, Female | 2 | 2015 | 192 | 0.170 |
Why?
|
Registries | 1 | 2016 | 8223 | 0.170 |
Why?
|
Nasal Bone | 2 | 2013 | 57 | 0.170 |
Why?
|
Humans | 99 | 2023 | 761423 | 0.160 |
Why?
|
Karyotyping | 7 | 2000 | 1171 | 0.160 |
Why?
|
Parity | 2 | 2010 | 927 | 0.160 |
Why?
|
Ovary | 1 | 2003 | 959 | 0.160 |
Why?
|
Foreign-Body Migration | 2 | 2010 | 219 | 0.150 |
Why?
|
Amniocentesis | 1 | 1998 | 115 | 0.150 |
Why?
|
Suture Techniques | 1 | 2003 | 771 | 0.150 |
Why?
|
Chromosome Aberrations | 2 | 2002 | 1771 | 0.150 |
Why?
|
alpha-Fetoproteins | 2 | 2002 | 223 | 0.150 |
Why?
|
Medical Oncology | 3 | 2014 | 2321 | 0.140 |
Why?
|
Obstetric Labor Complications | 1 | 1999 | 236 | 0.140 |
Why?
|
Clubfoot | 1 | 1998 | 87 | 0.140 |
Why?
|
Cleft Lip | 1 | 2002 | 506 | 0.140 |
Why?
|
Organ Size | 3 | 2018 | 2254 | 0.140 |
Why?
|
Cleft Palate | 1 | 2002 | 589 | 0.140 |
Why?
|
Amniotic Band Syndrome | 1 | 1996 | 22 | 0.140 |
Why?
|
Mothers | 2 | 2004 | 2192 | 0.140 |
Why?
|
Sacrococcygeal Region | 1 | 1996 | 53 | 0.130 |
Why?
|
Kidney | 1 | 2011 | 7049 | 0.130 |
Why?
|
Teratoma | 2 | 1996 | 404 | 0.130 |
Why?
|
Retrospective Studies | 25 | 2021 | 80582 | 0.130 |
Why?
|
Postmenopause | 1 | 2005 | 2513 | 0.130 |
Why?
|
Scrotum | 1 | 1995 | 116 | 0.120 |
Why?
|
Adult | 40 | 2021 | 221148 | 0.120 |
Why?
|
Pelvis | 2 | 2015 | 732 | 0.120 |
Why?
|
Fallopian Tube Diseases | 1 | 2015 | 60 | 0.120 |
Why?
|
Femur | 1 | 2001 | 1307 | 0.120 |
Why?
|
Abdominal Neoplasms | 1 | 1996 | 287 | 0.120 |
Why?
|
Logistic Models | 10 | 2008 | 13255 | 0.110 |
Why?
|
Pregnancy Complications, Neoplastic | 1 | 1996 | 258 | 0.110 |
Why?
|
Uterine Artery Embolization | 1 | 2014 | 59 | 0.110 |
Why?
|
Risk Factors | 15 | 2023 | 74167 | 0.110 |
Why?
|
Infant, Newborn | 14 | 2023 | 26212 | 0.110 |
Why?
|
Hernia, Inguinal | 1 | 1995 | 220 | 0.110 |
Why?
|
Urology | 2 | 2014 | 400 | 0.100 |
Why?
|
Chi-Square Distribution | 3 | 2011 | 3418 | 0.100 |
Why?
|
Varicose Veins | 1 | 2014 | 155 | 0.100 |
Why?
|
United States | 20 | 2021 | 72339 | 0.100 |
Why?
|
Endometriosis | 2 | 2015 | 869 | 0.090 |
Why?
|
Hydronephrosis | 1 | 2012 | 271 | 0.090 |
Why?
|
Amniotic Fluid | 2 | 2007 | 378 | 0.090 |
Why?
|
Polycystic Ovary Syndrome | 1 | 2015 | 376 | 0.090 |
Why?
|
Obstetric Labor, Premature | 1 | 2011 | 272 | 0.090 |
Why?
|
Sensitivity and Specificity | 8 | 2021 | 14664 | 0.090 |
Why?
|
Diagnosis, Differential | 9 | 2019 | 12970 | 0.080 |
Why?
|
Pregnancy Complications, Cardiovascular | 1 | 2014 | 515 | 0.080 |
Why?
|
Ultrasonography, Doppler | 2 | 2015 | 461 | 0.080 |
Why?
|
Infertility, Female | 1 | 2015 | 760 | 0.080 |
Why?
|
Restraint, Physical | 1 | 2010 | 187 | 0.080 |
Why?
|
Pre-Eclampsia | 1 | 1997 | 1231 | 0.070 |
Why?
|
Uterine Diseases | 1 | 2008 | 108 | 0.070 |
Why?
|
Odds Ratio | 6 | 2008 | 9645 | 0.070 |
Why?
|
Prenatal Diagnosis | 2 | 2023 | 1265 | 0.060 |
Why?
|
Cerebral Ventricles | 1 | 2007 | 542 | 0.060 |
Why?
|
Crown-Rump Length | 2 | 2014 | 32 | 0.060 |
Why?
|
Aging | 1 | 2003 | 8705 | 0.060 |
Why?
|
Prospective Studies | 9 | 2015 | 54415 | 0.050 |
Why?
|
Contrast Media | 4 | 2019 | 5311 | 0.050 |
Why?
|
Delivery, Obstetric | 2 | 2000 | 940 | 0.050 |
Why?
|
Neoplasms, Fibroepithelial | 1 | 2001 | 8 | 0.050 |
Why?
|
Family Planning Services | 1 | 2004 | 268 | 0.050 |
Why?
|
Labor, Induced | 2 | 2001 | 151 | 0.050 |
Why?
|
Chromosomes, Human, Pair 13 | 1 | 2002 | 192 | 0.050 |
Why?
|
Maternal Welfare | 1 | 2002 | 112 | 0.050 |
Why?
|
Chromosomes, Human, Pair 18 | 1 | 2002 | 247 | 0.050 |
Why?
|
Boston | 3 | 2004 | 9330 | 0.050 |
Why?
|
Religion | 1 | 2004 | 372 | 0.050 |
Why?
|
Physician Assistants | 1 | 2003 | 191 | 0.050 |
Why?
|
Head and Neck Neoplasms | 1 | 1995 | 2892 | 0.050 |
Why?
|
Follicle Stimulating Hormone | 1 | 2003 | 726 | 0.050 |
Why?
|
Fetal Macrosomia | 1 | 2001 | 141 | 0.040 |
Why?
|
Luteinizing Hormone | 1 | 2003 | 820 | 0.040 |
Why?
|
Neoplasm Staging | 3 | 2018 | 11106 | 0.040 |
Why?
|
Confidence Intervals | 3 | 2001 | 2927 | 0.040 |
Why?
|
Fetal Monitoring | 1 | 2000 | 69 | 0.040 |
Why?
|
Dandy-Walker Syndrome | 1 | 2000 | 45 | 0.040 |
Why?
|
Polydactyly | 1 | 2000 | 56 | 0.040 |
Why?
|
Reference Values | 3 | 2010 | 4921 | 0.040 |
Why?
|
Labor Presentation | 1 | 2000 | 55 | 0.040 |
Why?
|
Extraembryonic Membranes | 1 | 1999 | 38 | 0.040 |
Why?
|
Oxytocin | 2 | 2001 | 402 | 0.040 |
Why?
|
Toes | 1 | 2000 | 209 | 0.040 |
Why?
|
Yolk Sac | 1 | 1999 | 79 | 0.040 |
Why?
|
Kidney Tubules | 1 | 2001 | 449 | 0.040 |
Why?
|
Mass Screening | 1 | 2015 | 5428 | 0.040 |
Why?
|
Predictive Value of Tests | 6 | 2013 | 15262 | 0.040 |
Why?
|
Cause of Death | 1 | 2010 | 3684 | 0.040 |
Why?
|
Observer Variation | 3 | 2007 | 2605 | 0.040 |
Why?
|
Labor, Obstetric | 1 | 2002 | 323 | 0.040 |
Why?
|
Critical Care | 1 | 2011 | 2697 | 0.040 |
Why?
|
Urine | 1 | 2000 | 362 | 0.040 |
Why?
|
Congenital Abnormalities | 2 | 2000 | 709 | 0.040 |
Why?
|
Heart Defects, Congenital | 1 | 1995 | 4696 | 0.040 |
Why?
|
Biometry | 1 | 2001 | 563 | 0.040 |
Why?
|
Fingers | 1 | 2000 | 507 | 0.040 |
Why?
|
HELLP Syndrome | 1 | 1997 | 40 | 0.040 |
Why?
|
Urinary Bladder | 2 | 2000 | 1152 | 0.030 |
Why?
|
Reproducibility of Results | 4 | 2013 | 20093 | 0.030 |
Why?
|
Endosonography | 1 | 2000 | 609 | 0.030 |
Why?
|
Testicular Hydrocele | 1 | 1995 | 27 | 0.030 |
Why?
|
Preoperative Care | 1 | 2005 | 2242 | 0.030 |
Why?
|
Polyhydramnios | 1 | 1995 | 41 | 0.030 |
Why?
|
Spermatic Cord Torsion | 1 | 1995 | 72 | 0.030 |
Why?
|
Gynecology | 1 | 2021 | 526 | 0.030 |
Why?
|
Fetal Membranes, Premature Rupture | 1 | 1996 | 137 | 0.030 |
Why?
|
Vagina | 2 | 2016 | 838 | 0.030 |
Why?
|
Cicatrix | 1 | 2021 | 798 | 0.030 |
Why?
|
Facial Neoplasms | 1 | 1995 | 125 | 0.030 |
Why?
|
Appendicitis | 1 | 2001 | 675 | 0.030 |
Why?
|
Risk Assessment | 5 | 2013 | 23990 | 0.030 |
Why?
|
Cervical Vertebrae | 1 | 2000 | 981 | 0.030 |
Why?
|
Reproductive Medicine | 1 | 2015 | 99 | 0.030 |
Why?
|
Anthropometry | 1 | 1998 | 1349 | 0.030 |
Why?
|
Case-Control Studies | 3 | 2003 | 22168 | 0.030 |
Why?
|
Prognosis | 4 | 2014 | 29620 | 0.030 |
Why?
|
Rotation | 1 | 1995 | 517 | 0.030 |
Why?
|
Abortion, Induced | 2 | 2014 | 462 | 0.030 |
Why?
|
Magnetic Resonance Imaging | 4 | 2018 | 36423 | 0.020 |
Why?
|
Follow-Up Studies | 5 | 2013 | 39117 | 0.020 |
Why?
|
Age Factors | 2 | 2010 | 18400 | 0.020 |
Why?
|
Societies | 1 | 2011 | 108 | 0.020 |
Why?
|
Socioeconomic Factors | 1 | 2004 | 7825 | 0.020 |
Why?
|
Gravidity | 1 | 2010 | 50 | 0.020 |
Why?
|
Prevalence | 2 | 2000 | 15717 | 0.020 |
Why?
|
Abdomen | 1 | 2016 | 1128 | 0.020 |
Why?
|
Regression Analysis | 1 | 1999 | 6343 | 0.020 |
Why?
|
Likelihood Functions | 2 | 2002 | 992 | 0.020 |
Why?
|
Tomography, X-Ray Computed | 3 | 2016 | 20556 | 0.020 |
Why?
|
Urinary Bladder Neoplasms | 1 | 2001 | 2223 | 0.020 |
Why?
|
Pilot Projects | 2 | 2005 | 8633 | 0.020 |
Why?
|
Ultrasonography, Interventional | 1 | 2016 | 1495 | 0.020 |
Why?
|
Liver Diseases | 1 | 1996 | 1297 | 0.020 |
Why?
|
Calcinosis | 1 | 1996 | 1469 | 0.020 |
Why?
|
Massachusetts | 2 | 2013 | 8832 | 0.020 |
Why?
|
Genetic Testing | 1 | 1998 | 3538 | 0.020 |
Why?
|
Middle Aged | 8 | 2014 | 220826 | 0.010 |
Why?
|
Neutrophils | 1 | 1997 | 3766 | 0.010 |
Why?
|
Early Detection of Cancer | 1 | 2017 | 3201 | 0.010 |
Why?
|
Organizational Case Studies | 1 | 2003 | 301 | 0.010 |
Why?
|
Professional Autonomy | 1 | 2003 | 171 | 0.010 |
Why?
|
Male | 7 | 2014 | 360736 | 0.010 |
Why?
|
Incidence | 2 | 2013 | 21341 | 0.010 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2018 | 9277 | 0.010 |
Why?
|
Pregnancy Tests | 1 | 1999 | 33 | 0.010 |
Why?
|
Cesarean Section, Repeat | 1 | 1999 | 28 | 0.010 |
Why?
|
Polyps | 1 | 2001 | 200 | 0.010 |
Why?
|
Severity of Illness Index | 2 | 2012 | 15838 | 0.010 |
Why?
|
Risk | 1 | 2011 | 9612 | 0.010 |
Why?
|
Pregnancy, Ectopic | 1 | 1999 | 142 | 0.010 |
Why?
|
Diploidy | 1 | 1998 | 132 | 0.010 |
Why?
|
Adolescent | 3 | 2014 | 88313 | 0.010 |
Why?
|
Pediatrics | 1 | 2012 | 3595 | 0.010 |
Why?
|
Fatal Outcome | 1 | 2001 | 1834 | 0.010 |
Why?
|
Dinoprostone | 1 | 1999 | 597 | 0.010 |
Why?
|
Probability | 1 | 2001 | 2478 | 0.010 |
Why?
|
Time Factors | 3 | 2006 | 39975 | 0.010 |
Why?
|
Evaluation Studies as Topic | 1 | 1998 | 1626 | 0.010 |
Why?
|
Leiomyoma | 1 | 2000 | 636 | 0.010 |
Why?
|
Medical Records | 1 | 2001 | 1407 | 0.010 |
Why?
|
ROC Curve | 1 | 2002 | 3580 | 0.010 |
Why?
|
Hysterectomy | 1 | 1999 | 857 | 0.010 |
Why?
|
Quality Assurance, Health Care | 1 | 2003 | 2169 | 0.010 |
Why?
|
Radionuclide Imaging | 1 | 1997 | 1975 | 0.010 |
Why?
|
Linear Models | 1 | 2002 | 5869 | 0.010 |
Why?
|
Cohort Studies | 2 | 2008 | 41446 | 0.010 |
Why?
|
Uterine Neoplasms | 1 | 2000 | 1420 | 0.010 |
Why?
|
Infant | 1 | 2012 | 36205 | 0.010 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2001 | 10766 | 0.000 |
Why?
|
Aged, 80 and over | 1 | 2013 | 58956 | 0.000 |
Why?
|
Heart Ventricles | 1 | 1998 | 3816 | 0.000 |
Why?
|
Aged | 1 | 2013 | 169235 | 0.000 |
Why?
|
Genetic Predisposition to Disease | 1 | 2000 | 17912 | 0.000 |
Why?
|
Child, Preschool | 1 | 2000 | 42254 | 0.000 |
Why?
|
Brain | 1 | 2000 | 27107 | 0.000 |
Why?
|
Child | 1 | 2000 | 80162 | 0.000 |
Why?
|